[Author’s Name]
[Institution’s Name]
Essay on The World of Johnson & Johnson
Introduction
Johnson & Johnson is a global manufacturer of health care products as well as a provider of related health services. The company operates predominantly through three segments: consumer, medical devices & diagnostics, and pharmaceutical. The company's medical devices and diagnostics segment includes a broad array of products used principally in the professional fields of physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. Distribution to these markets is done both directly to health care professionals and indirectly through surgical supply dealers and other dealers. Product lines include surgical implants, instruments, needles and sutures; blood glucose monitoring systems; wound closure devices; endoscopic instruments; orthopedic products for joint repair and replacement and for correcting spinal deformities; contact lenses; clinical chemistry systems; medical devices, including cardiovascular monitoring and vascular access products; intravenous catheters and shunts; coronary and biliary stents. Professional products generate around 35% of the overall sales revenues. (Aldana 2001)
Mention Johnson & Johnson to the average investor, and the name conjures images of Band-Aids and baby powder. That's a problem for longtime chief executive Ralph Larsen. For as much as Larsen loves Band-Aids--and he's got four different varieties displayed on his desk--the CEO knows that boo-boos and baby bottoms don't fit the image of a high-multiple growth stock. Larsen points out that it's been years since consumer goods were Johnson & Johnson's most important business. Band-Aid, Tylenol, Neutrogena and all its other brand-name products now generate a mere 13% of operating profits. The big money is being made by its pharmaceuticals unit, home to quieter bestsellers like Ortho Tri-cyclen, Procrit and Risperdal. In all, prescription drugs account for a whopping 63% of J&J's earnings, a percentage likely to rise, barring a sudden outbreak of skinned knees and chafed tushies.
While he might get an argument on that last point, there's no question that with $12 billion in prescription drug sales last year--and an acquisition of pharmaceutical up-and-comer Alza Corp....
This essay has the followings:
Total words: 2,861
Total reference: 7
Total price: £ 49.95
Click here to Order this essay!
Get Professionally written Essays that are:
• Written According to your Exact Requirements
• 100% Original and Non-Plagiarized
• Written by Expert
UK Writers
• Delivered to you before your deadline
Amazingly Low Prices - £9.95/page
